Maurice Blake says he never knew that one-in-four black men face prostate cancer - double the average.

A cancer dietitian has said cutting just two foods from your diet can instantly slash your risk of multiple types of cancer, ...

The team, which is led from Institut Imagine by Paul Bastard, will receive up to $25m over approximately five years to take on the challenge of cancer avoidance.

The results of this study by Cima Universidad de Navarra will enable more personalised medicine that identifies the ...

The Prostate Cancer Foundation (PCF) today announced a $10 million unrestricted gift from an anonymous donor to launch a TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) Award, which will ...

Attention red wine drinkers: Drinking moderate amounts of any kind of alcohol (including wine, beer, and liquor) is associated with a slightly increased breast cancer risk -- and the rosy-hued ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease.

Cancer-related NHS hospital care costs by stage at diagnosis differed between cancer types; this heterogeneous pattern could inform detailed and nuanced economic evaluations of early detection ...

The National Cancer Institute (NCI), the federal research agency charged with leading the war against the nation's second-largest killer, is studying ivermectin as a potential cancer treatment, ...

Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...

DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) today announced a significant expansion of oncology research capabilities within its Accellacare Site Network through the opening of the Brian Moran ...

AstraZeneca is showing no signs of restarting a 200 million pound sterling ($273 million) investment in its U.K. hometown, despite keeping its options open. AstraZeneca paused the investment in its ...